Cargando…
Role of ischemia-modified albumin in patients with acute decompensated heart failure
Autores principales: | Pan, Defeng, Li, Dongye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336860/ https://www.ncbi.nlm.nih.gov/pubmed/26301345 http://dx.doi.org/10.5152/AnatolJCardiol.2015.18405 |
Ejemplares similares
-
Tolvaptan in the very elderly with acute decompensated heart failure-a therapeutic option worth of consideration
por: Ndrepepa, Gjin
Publicado: (2017) -
Is Protein Kinase C Inhibition the Tip of the Iceberg in New Therapeutics for Acutely Decompensated Heart Failure?
por: Pimental, David R., et al.
Publicado: (2017) -
Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2016) -
Repetitive Acute Hemodynamic Load: Progression From Systolic Decompensation to Cellular/Extracellular Compensation to Diastolic Decompensation
por: Zile, Michael R., et al.
Publicado: (2019) -
The relevance of serum albumin among elderly patients with acute decompensated heart failure
por: Mene-Afejuku, Tuoyo O, et al.
Publicado: (2019)